StopAfib.org interviews Dr. Kenneth Ellenbogen of Virginia Commonwealth University. In this video, Dr. Ellenbogen talked about some of the exciting things for afib patients being presented at the 2010 American Heart Association Scientific Sessions. He discussed the presentation of the ROCKET AF clinical trial, which could provide a second new alternative to warfarin for afib …
Read More
In this video, Dr. John Sirak, of the Ohio State University Medical Center (Columbus, OH), talks about the 5-box total thoracoscopic maze procedure, a minimally-invasive surgical procedure for afib that is achieving good results, even among those with persistent or longstanding persistent atrial fibrillation. This video is a companion to our previous article, New Mini …
Read More
In this video, cardiothoracic surgeon Dr. James Edgerton of The Heart Hospital Baylor Plano (Plano, TX) consults with an afib patient and caregiver about various atrial fibrillation treatment options, including medications, cardioversions, catheter ablation, and surgical procedures. Dr. Edgerton is a board-certified cardothoracic surgeon at the Heart Hospital Baylor Plano, an Adjunct Assistant Clinical Professor …
Read More
Wednesday, January 18, 2012 8:30 a.m. breakfast 9:00 - 10:00 a.m. program National Press Club 529 14th Street NW Washington, DC Plan to join WomenHeart: The National Coalition for Women with Heart Disease for a special presentation about the Million Hearts campaign. Million Hearts – a joint initiative of the Centers for Disease Control and …
Read More
Results from FAST, the first-ever randomized trial to compare the effectiveness of minimally invasive surgical ablation (also called the mini maze procedure) for atrial fibrillation and catheter ablation for afib, were presented at the recent American Heart Association meeting. The FAST study enrolled patients who had failed a previous catheter ablation procedure. The minimally invasive …
Read More
Our January EP Lab Digest Patient Perspective column, Stuck in the Middle: Afib Patients on Rate Control, focuses on how rate control treatment (such as beta blockers) alone impacts the quality of life of those living with atrial fibrillation. The column also explores things doctors and patients may wish to consider in determining an appropriate …
Read More
The Food and Drug Administration (FDA) approved the AtriCure Synergy Ablation System for the treatment of persistent and longstanding persistent atrial fibrillation in patients undergoing another heart surgery. The Synergy bipolar radiofrequency clamp is the only surgical ablation device with FDA approval for afib treatment. Learn more: FDA Advisory Panel Recommends, and FDA Approves, Bipolar …
Read More